Vir Biotechnology, Inc.
Overview
Vir Biotechnology, Inc. is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The company is dedicated to creating solutions by utilizing various platforms, including monoclonal antibody, T cell and small interfering ribonucleic acid platforms.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Vir Biotechnology, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Vir Biotechnology, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.